Mathes Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Mathes Company, Inc.
- $274 Million
- Q4 2024
A detailed history of Mathes Company, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Mathes Company, Inc. holds 7,645 shares of XBI stock, worth $645,238. This represents 0.25% of its overall portfolio holdings.
Number of Shares
7,645
Previous 9,115
16.13%
Holding current value
$645,238
Previous $901,000
23.53%
% of portfolio
0.25%
Previous 0.32%
Shares
14 transactions
Others Institutions Holding XBI
# of Institutions
916Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$941 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$858 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$806 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$719 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$676 Million0.06% of portfolio